Form 10-Q PLIANT THERAPEUTICS, For: Mar 31

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. MRK
7. LVS
8. SAP
9. CSX
10. LRCX

Go back to Form 10-Q PLIANT THERAPEUTICS, For: Mar 31

Pliant Therapeutics (PLRX) PT Lowered to $45 at RBC Capital

May 7, 2024 6:19 AM EDT

RBC Capital analyst Brian Abrahams lowered the price target on Pliant Therapeutics (NASDAQ: PLRX) to $45.00 (from $54.00) while maintaining a Outperform rating.

The analyst comments "PLRX's IPF program remains on track with the ph.IIb expected to complete enrollment 1Q25. While this likely... More

Pliant Therapeutics (PLRX) PT Lowered to $44 at Citi

May 7, 2024 5:46 AM EDT

Citi analyst David Lebowitz lowered the price target on Pliant Therapeutics (NASDAQ: PLRX) to $44.00 (from $45.00) while maintaining a Buy rating.

The analyst comments "Pliant reported 1Q24 financial results and provided an update on the status of its pipeline programs. Over the... More